Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-11

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to test a new treatment of social cognition deficits in patients with schizophrenia or schizoaffective disorder by transcranial magnetic stimulation (theta-burst). The study will also identify clinical, psychomotor and cognitive variables that are the most sensitive to treatment, and estimate the most sensitive treatment target between patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treating Social Cognition With Theta Burst Stimulation; a Pilot Sudy

NCT02440867

Social Cognition in Patients With Schizophrenia

UNKNOWN NA

Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia

NCT01315587

Schizophrenia

UNKNOWN PHASE2

Theta Burst Stimulation for Schizophrenia

NCT03288779

Schizophrenia Schizoaffective Disorder

COMPLETED NA

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders

NCT04418011

Schizophrenia Schizoaffective Disorder Schizophreniform Disorders

COMPLETED NA

Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation

NCT02670291

Auditory Hallucinations Schizophrenia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The language understanding of other people is based on linguistic decoding mechanisms (phonological, semantic, syntactic ...) but also more on subtle mechanisms for the recognition of emotions and intentions. Interact with another one requires understanding its language but also to infer emotions and intentions. There are patients with schizophrenia suffering from social cognition disorders that impair social interactions; These patients often have difficulty in extracting the non-verbal emotional content of language and have difficulty inferring the thoughts and intentions of others. Recently, investigators have suggested a link between such deficits and the hypofunction of the medial prefrontal cortex.

Transcranial magnetic stimulation is a noninvasive neuromodulation technique that increases or decreases the focal cortical excitability depending on stimulation parameters. This technique is now commonly used as a therapeutic tool. It has been tried with some success in patients with schizophrenia in some indications:

* To reduce the auditory verbal hallucinations stimulating the temporal cortex
* More rarely, to reduce the negative symptoms stimulating the dorsolateral prefrontal cortex.

So far, the medial prefrontal cortex was not considered as a possible target as the scalp to cortex distance prevent from using conventional stimulation coils. Recently new coils have been developed that permit stimulation of deeper cortical regions.

Investigators hypothesize that the use of transcranial magnetic stimulation with a theta burst intermittent protocol known to increase the cortical excitability and aiming the medial prefrontal cortex with a special antenna will improve social interaction capabilities of schizophrenic patients.

In this multicentric study, involving 61 patients, investigators plan to assess the social cognition deficits before and after 10 sessions of magnetic stimulation (2 sessions per day for 5 consecutive days) using a neuronavigation system and Magstim® stimulator. In order to assess the specificity of the stimulation of medial prefrontal cortex (MPC), the effects of this treatment will be compared to the effects of the same treatment aiming the dorsolateral prefrontal cortex (DLPFC), also involved in aspects of negative symptoms of schizophrenia, and placebo effects induced by sham stimulation (using a sham coil). An anatomical MRI will be performed before the treatment to define the targets. Moreover, changes motor activity will be observed after stimulation thanks to continuous actimetry recording.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Cognition in Patients With Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TBS-MPC

Intervention with Magstim® Active TBS aiming Medial Prefrontal Cortex in 18 patients with schizophrenia

Group Type EXPERIMENTAL

Magstim® Active TBS

Intervention Type DEVICE

Non-invasive transcranial magnetic stimulation inducing changes in cortical excitability depending on the cortical target (except for sham stimulation)

TBS-CPDLF

Intervention with Magstim® Active TBS aiming Dorsolateral Prefrontal Cortex in 18 patients with schizophrenia

Group Type ACTIVE_COMPARATOR

Magstim® Active TBS

Intervention Type DEVICE

Non-invasive transcranial magnetic stimulation inducing changes in cortical excitability depending on the cortical target (except for sham stimulation)

TBS-Sham

Intervention with Magstim® Sham TBS in 25 patients with schizophrenia

Group Type SHAM_COMPARATOR

Magstim® Sham TBS

Intervention Type DEVICE

Sham stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magstim® Active TBS

Non-invasive transcranial magnetic stimulation inducing changes in cortical excitability depending on the cortical target (except for sham stimulation)

Intervention Type DEVICE

Magstim® Sham TBS

Sham stimulation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* with a diagnosis of schizophrenia or schizoaffective disorder (DSM-IV MINI R)
* Having signed a written informed consent
* 'Lecture Intentionnelle en situation' (LIS) score \> 15 or negative 'Positive and Negative Syndrome Scale' (PANSS) score \> 15

Exclusion Criteria

* Any change in psychotropic drugs (antidepressants, antipsychotics or mood stabilizers) during the two months preceding the inclusion
* Pregnant or breastfeeding women
* Subjects with a neurological condition or with epilepsy
* Subjects with a counter-indication to MRI or Transcranial stimulation (electronic or metal implants)
* Subjects that refuse to wear earplugs during MRI

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No